Barbara Menzaghi

Statistics

Publications

Citations

1.8K

H-Index

Active since

2006

Affiliations

Ospedale di Circolo di Busto Arsizio(Current)

University of Sassari

Alessandro Manzoni Hospital

Ospedale Policlinico San Martino

University of Milano-Bicocca

Barbara Menzaghi is an author at Ospedale di Circolo di Busto Arsizio specializing in antiretroviral therapy, antiviral therapy, and infectious diseases.

ORCID

Publications per year

2006–2024

Publications

Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

Pedro Cahn, Juan Sierra Madero, José Ramón Arribas et al. · The Lancet · 2018 · 381 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C

Roberta D’Ambrosio, L. Pasulo, Massimo Puoti et al. · Journal of Hepatology · 2018 · 132 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +13

Weight Gain: A Possible Side Effect of All Antiretrovirals

Lucia Taramasso, Elena Ricci, Barbara Menzaghi et al. · Open Forum Infectious Diseases · 2017 · 89 citations · Full text

Public Health, Infectious Diseases, Hiv Control +14

Factors Associated With Weight Gain in People Treated With Dolutegravir

Lucia Taramasso, Paolo Bonfanti, Elena Ricci et al. · Open Forum Infectious Diseases · 2020 · 70 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +17

Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients

Daniela Mologni, Paola Citterio, Barbara Menzaghi et al. · AIDS · 2006 · 64 citations

Life Sciences, Infectious Diseases, Molecular Biology +17

1–5 of 46